Gurobi to Bring Decision Intelligence Summit to Vienna
The Gurobi Summit EMEA returns October 28-29 to showcase the latest innovations in optimization.
Gurobi Optimization, LLC, the leader in decision intelligence technology, is pleased to announce the return of its Decision Intelligence Summit (“Gurobi Summit”) to the EMEA region. The event will take place October 28-29 at the Hofburg Conference Centre in Vienna, where another record-breaking year in attendance is expected.
Following September’s summit for the Americas, this year’s EMEA event will focus on the theme “Empowering Bold Decisions,” bringing together business leaders and technical practitioners to explore how mathematical optimization and decision intelligence can drive real-world impact.
Organizations speaking at the event will include: A1 Telekom, Agora, Airbus, Danone, Gousto, Iberia, Kärnten University of Applied Science, Levasoft, MC Sonae, o9 Solutions, POLYPOINT, SAP, and Turkish Airlines. In addition, event sponsors Capgemini, Decide4AI, LTPlabs, and ORMAE will be present to showcase their insights, while Gurobi’s leaders will share a preview of the product roadmap.
Attendees will have the opportunity to choose between specialized business and technical sessions, as well as book one-to-one meetings with Gurobi’s experts to discuss their models and individual use cases.
"The Gurobi Summit embodies our commitment to empowering bold, data-driven decisions,” said Duke Perrucci, CEO of Gurobi Optimization. “We’re thrilled to bring this event to Vienna and once again connect with innovators from across the EMEA region, exchange insights, and inspire new possibilities."
To learn more about the Gurobi Summit EMEA and to view the full agenda, visit the official event website.
About Gurobi Optimization
With Gurobi’s decision intelligence technology, customers can make optimal business decisions in seconds. From workforce scheduling and portfolio optimization to supply chain design and everything in between, Gurobi identifies the optimal solution, out of trillions of possibilities.
As the leader in decision intelligence, Gurobi delivers easy-to-integrate, full-featured software and best-in-class support, with an industry-leading 98% customer satisfaction rating.
Founded in 2008, Gurobi has operations in the Americas, Europe, and Asia. It serves customers in nearly all industries, including organizations like SAP, Air France, and the National Football League. For more information, please visit https://www.gurobi.com/ or call +1 713 871 9341.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251001186520/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
QNB Group Receives Saudi Central Bank “SAMA” License Approval for a New Digital Bank “ezbank”1.10.2025 18:20:00 CEST | Press release
In co-operation with Ajlan & Bros. Holding Introducing a new model of customer-centric banking built around innovation, efficiency, and accessibility. Providing innovative solutions for the youth and entrepreneurs. QNB Group, the largest financial institution in the Middle East and Africa, announced the license approval has been received for a digital-first banking entity, ezbank, from the Saudi Central Bank ”SAMA”, in cooperation with Ajlan & Bros. Holding, with a capital of SAR 2.5 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251001012393/en/ QNB Group Corporate Headquarters (Photo: AETOSWire) This milestone, in cooperation with Ajlan & Bros. Holding, reflects a commitment to supporting QNB Group’s vision for financial inclusion and digital transformation, as well as the broader economic development strategy. With ezbank, the goal is to introduce a new model of customer-centric banking built around innovation, e
CompareForexBrokers: Seven Major Forex Pairs Slip to 66.3% of Global Turnover1.10.2025 17:02:00 CEST | Press release
2025 BIS Triennial Survey data shows major pair concentration down 18.7% from 2022 CompareForexBrokers has analysed the latest Triennial Survey from the Bank for International Settlements, published 30 September 2025, and found the seven major currency pairs are losing dominance in global foreign exchange markets. While 85% of forex transactions consisted of the seven majors in 2022, their share has since dropped to 66.3% in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251001844788/en/ Daily Turnover On Forex Markets Despite the 18.7% drop in major pairs, overall activity has increased considerably, with daily turnover rising 28% to 9.6 trillion USD. On an annual basis, that equates to 3.5 quadrillion USD, up from 2.73 quadrillion in 2022. More data can be found on the forex statistics page. “Our biggest take away from yesterday’s BIS data release is foreign exchange remains the largest financial market, but the comp
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub1.10.2025 16:59:00 CEST | Press release
The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, today announced a new research and development (R&D) partnership with the AstraZeneca BioVentureHub in Gothenburg, Sweden. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251001395504/en/ Thermo Fisher Bioanalytical lab The partnership aims to leverage the combined expertise of Thermo Fisher and AstraZeneca to drive innovation and strengthen the life science ecosystem. A dedicated team from Thermo Fisher will co-locate with AstraZeneca scientists to work on collaborative R&D projects with a focus initially on chromatography, molecular genomics and proteomics. "This is a unique opportunity to co-locate with AstraZeneca scientists, driving collaborative innovation, strengthening the science ecosystem and driving value generation for all collaborators, giving easy access to cutting edge technologies for emerging life sciences an
Pure Lithium Partners with Voltaiq to Accelerate Commercialization1.10.2025 15:15:00 CEST | Press release
Voltaiq’s battery quality analytics platform to power the commercialization of Pure Lithium’s lithium metal battery technology Pure Lithium, a disruptive vertically integrated lithium metal battery technology company, has selected Voltaiq’s Enterprise Battery Intelligence platform to provide battery analytics and quality control that are essential to Pure Lithium’s drive to commercialize its next generation lithium metal battery, the two companies announced today. The partnership with Voltaiq, the industry leader in battery quality analytics software, comes at a crucial time for Pure Lithium as it relocates to Chicago, builds out its first pilot line, and begins shipping sample cells to customers. Pure Lithium previously relied on its own internal analytics system. As the company shifts focus from R&D to commercialization, the team turned to Voltaiq to provide a platform that can scale with the business – including advanced analytics – as well as a partner with deep battery and softwar
Blue Matter Hires New Partner, Eva Kersey, Further Strengthening Capabilities in Europe1.10.2025 15:05:00 CEST | Press release
Blue Matter is pleased to announce that Eva Kersey has joined the firm as a Partner based in London. Eva officially joined the Blue Matter team on September 16, bringing a broad base of strategic consulting experience across pharmaceutical, biotech, and medical technology clients. Eva has been serving life science clients since 2007. She began her consulting career at PHP (now a part of Accenture). Since then, she has served in leadership and Partner-level positions at IMS Consulting, IQVIA, and ClearView Healthcare Partners. Over the years, her consulting experience has spanned the full value chain, focusing on cross-functional strategy development. She brings a particular specialization in therapy and franchise strategy, portfolio optimization, and pricing, access and evidence strategy. She also brings significant expertise in all aspects of commercial strategy development for clinical-stage, pre-launch assets. “I’m extremely excited to join the Blue Matter team,” Eva said. “The firm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom